BioCentury
ARTICLE | Company News

Compugen management update

November 24, 2008 8:00 AM UTC

Compugen Ltd. (NASDAQ:CGEN), Tel Aviv, Israel Business: Gene/Cell therapy, Diagnostic, Computational chemistry/biology Transitioned: Martin Gerstel to president and CEO on Jan. 1, 2009, while remainin...